Gene therapy in the putamen for curing AADC deficiency and Parkinson's disease
Gene therapy in the putamen for curing AADC deficiency and Parkinson's disease
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
This commentary provides an overview of the putamen as an established target site for gene therapy in treating aromatic
l
‐amino acid decarboxylase (AADC) deficiency and Parkinson’s disease, two debilitating neurological disorders that involve motor dysfunction caused by dopamine deficiencies. The neuroanatomy and the function of the putamen...
Alternative Titles
Full title
Gene therapy in the putamen for curing AADC deficiency and Parkinson's disease
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_fb674fddecf64782b2382b315e8a5d34
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_fb674fddecf64782b2382b315e8a5d34
Other Identifiers
ISSN
1757-4676,1757-4684
E-ISSN
1757-4684
DOI
10.15252/emmm.202114712
